Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MeVis Medical Solutions AGFRA:M3V 69 Earnings per Share (Diluted) is €0.42 as of Mar. 2026. GuruFocus rates FRA:M3V with a GF Score™ of 69/100 and a GF Value™ of €22.29 (Fairly Valued). The stock has 5 warning signs investors should review. Among 502 Healthcare Providers & Services companies, MeVis Medical Solutions AG ranks worse than 86.65% on this metric.
During the past 13 years, MeVis Medical Solutions AG's highest 3-Year average EPS without NRI Growth Rate was 75.70% per year. The lowest was -65.20% per year. And the median was 2.20% per year.
MeVis Medical Solutions AG (FRA:M3V) Earnings per Share (Diluted) Explanation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
MeVis Medical Solutions AG Earnings per Share (Diluted) Related Terms
MeVis Medical Solutions AG Earnings per Share (Diluted) Historical Data
* Premium members only.
The historical data trend for MeVis Medical Solutions AG's Earnings per Share (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MeVis Medical Solutions AG Earnings per Share (Diluted) Chart
FRA:M3V vs VEEV, BTSG, TEM: Earnings per Share (Diluted) Comparison
For the Health Information Services subindustry, MeVis Medical Solutions AG's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MeVis Medical Solutions AG PE Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MeVis Medical Solutions AG's PE Ratio distribution charts can be found below:
* The bar in red indicates where MeVis Medical Solutions AG's PE Ratio falls into.
MeVis Medical Solutions AG Earnings per Share (Diluted) Calculation
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
MeVis Medical Solutions AG's Earnings Per Share (Diluted) for the fiscal year that ended in Sep. 2025 is calculated as
Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.42
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
What does a Earnings per Share (Diluted) of €0.42 mean?
MeVis Medical Solutions AG (FRA:M3V) has a Earnings per Share (Diluted) of €0.42 as of Mar. 2026. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on MeVis Medical Solutions AG and its competitors. According to the industry distribution chart, MeVis Medical Solutions AG ranks #435 out of 502 companies in the Healthcare Providers & Services industry, placing it in the top 86.7%.
Is MeVis Medical Solutions AG's Earnings per Share (Diluted) too high?
MeVis Medical Solutions AG's current Earnings per Share (Diluted) is €0.42. Based on the distribution chart, MeVis Medical Solutions AG ranks #435 out of 502 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, MeVis Medical Solutions AG has a GF Score™ of 69/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does MeVis Medical Solutions AG's Earnings per Share (Diluted) compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, MeVis Medical Solutions AG ranks #435 out of 502 companies for Earnings per Share (Diluted). This places MeVis Medical Solutions AG in the lower half of its industry. The industry median Earnings per Share (Diluted) is 10.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings per Share (Diluted) for a Healthcare Providers & Services company?
The median Earnings per Share (Diluted) among Healthcare Providers & Services companies is 10.70, based on 502 companies in the industry. Companies in the top quartile (top 25%) have a Earnings per Share (Diluted) significantly above this median, while those in the bottom quartile fall well below. However, Earnings per Share (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings per Share (Diluted) mean?
A high Earnings per Share (Diluted) can signal that a stock is expensive relative to its fundamentals. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on MeVis Medical Solutions AG and its competitors. For the Healthcare Providers & Services industry, the median Earnings per Share (Diluted) is 10.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MeVis Medical Solutions AG's current Earnings per Share (Diluted) is €0.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MeVis Medical Solutions AG stock overvalued right now?
Based on GuruFocus' analysis, MeVis Medical Solutions AG (FRA:M3V) is currently considered Fairly Valued. The stock's GF Value™ is €22.29, compared to a current price of €23.80 — trading 6.8% above its estimated fair value. The current Earnings per Share (Diluted) is €0.42. MeVis Medical Solutions AG's overall GF Score™ is 69/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings per Share (Diluted) calculated?
Earnings per Share (Diluted) is calculated from a company's financial statements. For MeVis Medical Solutions AG (FRA:M3V), the current Earnings per Share (Diluted) is €0.42 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MeVis Medical Solutions AG (FRA:M3V) Overvalued in 2026?
Based on GuruFocus' analysis, MeVis Medical Solutions AG stock appears to be overvalued.
The current stock price of €23.80 is trading 6.8% above its estimated GF Value™ of €22.29.
GuruFocus considers MeVis Medical Solutions AG to be Fairly Valued.
Key valuation signals for FRA:M3V:
Earnings per Share (Diluted): €0.42
GF Value™: €22.29 vs. price of €23.80 (6.8% above fair value)
No single metric tells the full story. See the FRA:M3V stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MeVis Medical Solutions AG is a provider of medical software products. The company markets its products to equipment manufacturer of medical devices and providers of medical information technology platforms. Its segment includes Digital mammography and Other diagnostics. The Digital mammography segment develops and markets software products which assist in breast diagnostic imaging and intervention. Its Other diagnostics segment consists of digital radiology products. In addition, it also provides the general analysis of radiology images. The company's geographical area of operations includes the United States of America and Europe.
69GF Score
Get the complete analysis for FRA:M3V
Earnings per Share (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:M3V has been successfully added to your 
